Elaine Mary Shannon insider trades: Takeda Pharmaceutical (TAK) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Elaine reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | TAK | ↓ Sell | 20,363 | $17.55 | $357K | Direct | Aug 12, 2026 (1d) |
| Aug 10, 2026 | TAK | ↓ Sell | 3,978 | $17.10 | $68K | Direct | Aug 12, 2026 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TAK insiders
Open-market trades in the last 12 months
About Elaine Mary Shannon's insider trades
Elaine Mary Shannon is Pres., Global Supply & Quality at Takeda Pharmaceutical (TAK). Since Aug 10, 2026, Elaine has reported no open-market purchases and 2 sales worth $425K on SEC Form 4. In the last 12 months: 2 sales ($425K).
Their filings also include grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TAK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.